Form 4: Precision BioSciences: Executive Awarded Stock Units

Dario Scimeca, General Counsel and Secretary of Precision BioSciences Inc., received an award of 107,604 restricted stock units.

Summary

• Dario Scimeca, General Counsel and Secretary of Precision BioSciences Inc. (DTIL), was awarded 107,604 restricted stock units (RSUs) on June 1, 2026.
• These RSUs represent a contingent right to receive one share of the Issuer's Common Stock per unit.
• The award vests in three substantially equal annual installments, commencing on February 18, 2027.
• Vesting is contingent upon Mr. Scimeca's continued service to the Issuer through each applicable vesting date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard executive compensation award rather than a significant financial event or strategic shift.

Positives

• Award of restricted stock units to a key executive, indicating potential alignment of executive interests with shareholder value.
• The award structure suggests a long-term incentive plan, encouraging executive retention and commitment.

Risks

• Vesting is contingent on continued service, meaning the executive could forfeit unvested units if employment terminates before vesting dates.
• The value of the award is subject to the future performance and stock price of Precision BioSciences Inc.

Future Outlook

The vesting schedule indicates a multi-year commitment from the executive, with the full benefit of the award realized over time, subject to continued employment.

Industry Context

StockSavvy.ai notes that equity awards to key executives are a common practice in the biotechnology sector to attract and retain talent, especially in companies focused on long-term research and development.

Stakeholder Impact

• Shareholders: The award aligns executive interests with long-term company performance, potentially benefiting shareholders if the company succeeds.
• Employees: May signal a stable leadership team, though the direct impact on other employees is minimal.
• Management: Reinforces the compensation structure for key executives.

Next Steps

• Continued service by Dario Scimeca to meet vesting requirements.
• Monitoring of Precision BioSciences Inc.'s performance and stock price impacting the value of the awarded RSUs.

Key Dates

Keywords

restricted stock units, executive compensation, Precision BioSciences, DTIL, stock award, insider transaction, Form 4